This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: University of Michigan. Active years: 2006-2025.
Company Filing History:
Years Active: 2006-2025
Title: Ajit P Joglekar: Innovator in Cancer Treatment
Introduction
Ajit P Joglekar is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a total of 4 patents, Joglekar is recognized for his work in activating mitotic checkpoint control mechanisms.
Latest Patents
One of his latest patents focuses on activating mitotic checkpoint control mechanisms. This patent provides compositions and methods for the treatment of cancer by activating the spindle assembly checkpoint (SAC) in cells. In particular, dimerized Mps1 and Spc105/KNL1 constructs are provided as tunable activators of SAC, allowing for control of chromosome segregation accuracy and prevention of aneuploidies that are common in cancer. Another significant patent by Joglekar involves the Mps1 and KNL1 phosphorylation system, which also aims to treat cancer by activating the spindle assembly checkpoint (SAC) in cells.
Career Highlights
Ajit P Joglekar is affiliated with the University of Michigan, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential impact on improving cancer therapies and patient outcomes.
Collaborations
Some of his notable coworkers include Alan Hunt and Edgar Meyhofer, who have collaborated with him on various research projects.
Conclusion
Ajit P Joglekar's innovative work in cancer treatment through his patented technologies highlights his significant contributions to the field. His research continues to pave the way for advancements in medical science and cancer therapies.